A positive relationship between headache and intracranial pressure has been observed, and specific signalling pathways have been speculated to be mechanistic drivers of IIH headaches
This is one of the most searched questions about this medication, and the honest answer is: it depends on the dose, the duration of treatment, and how consistently its combined with dietary and lifestyle changes
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
Frequently reported side effects include: Nausea Vomiting Diarrhea Constipation Stomach pain Reduced appetite Indigestion These symptoms are generally linked to the way GLP-1 drugs affect digestion and appetite regulation
Patients often experience nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when first starting the medication or increasing the dose
Furthermore, it was reported that this risk increases with the duration of exposure to GLP-1 receptor agonists, with the highest risk observed after 1.6 years